Published in Women's Health Weekly, August 5th, 2004
"This finding does not support a role for transdermal estrogen in the prevention of ischemic heart disease in postmenopausal women," wrote K. Lacut and colleagues, at Cavale Blanche Hospital, France.
"Mild hyperhomocysteinemia is a risk factor for both ischemic heart disease and venous thromboembolism. The effects of transdermal estrogen replacement therapy (ERT) on homocysteine metabolism in postmenopausal women have scarcely been investigated," the researchers said.
...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.